Evidence map›Paper›PMID 39859474›Full record

ArticleInternational journal of molecular sciences2025

Regulation of PHD2 by HIF-1α in Erythroid Cells: Insights into Erythropoiesis Under Hypoxia.

Shunjuan Wang, Qiying Xu, Wenjing Liu, Na Zhang, Yuelin Qi, Feng Tang, Rili Ge

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shunjuan WangResearch Center for High Altitude Medicine, Qinghai University, Xining 810016, China.
Qiying XuResearch Center for High Altitude Medicine, Qinghai University, Xining 810016, China.
Wenjing LiuResearch Center for High Altitude Medicine, Qinghai University, Xining 810016, China.
Na ZhangResearch Center for High Altitude Medicine, Qinghai University, Xining 810016, China.
Yuelin QiResearch Center for High Altitude Medicine, Qinghai University, Xining 810016, China.
Feng TangResearch Center for High Altitude Medicine, Qinghai University, Xining 810016, China.
Rili GeResearch Center for High Altitude Medicine, Qinghai University, Xining 810016, China.

Funding

National Natural Science Foundation of China 82360334
6 · The paper itself

Abstract

The hypoxia-inducible factor (HIF) pathway has been demonstrated to play a pivotal role in the process of high-altitude adaptation. PHD2, a key regulator of the HIF pathway, has been found to be associated with erythropoiesis. However, the relationship between changes in Phd2 abundance and erythroid differentiation under hypoxic conditions remains to be elucidated. A hemin-induced K562 erythroid differentiation model was used to explore the effects of PHD2 knockdown under hypoxia. Erythroid differentiation was assessed by flow cytometry and immunofluorescence. HIF-1α's regulation of PHD2 was examined using luciferase assays and ChIP-seq. CRISPR/Cas9 was applied to knock out

Indexed as

Erythroid CellsErythropoiesisHypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor-Proline DioxygenasesCell DifferentiationCell HypoxiaCRISPR-Cas SystemsGene Expression RegulationHumansK562 CellsEGLN1 protein, humanHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor-Proline Dioxygenasesendogenous PHD2 reporter systemserythroid differentiationHIF-1α

Identifiers

PMID39859474
PMCPMC11765976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.